Interleukin-6 (IL-6) is a pleiotropic cytokine that exerts multiple functions during the immune response, hemato-poiesis and acute-phase reaction [1]. It acts via a cell surface receptor complex composed of an IL-6-binding subunit (gp80) and a signal-transducing subunit (gpl30) which is also shared by some other cytokines, e.g. . The IL-6 receptor is expressed by a variety of cells including monocytes and macrophages [3, 4]. Since these cells display functional and phenotypic heterogeneity, we asked whether they might also differ with respect to the IL-6 receptor. Therefore, we studied the expression ofthe 1L-6 receptor subunits gp80 and gpl30 during in vitro maturation of monocytes to macrophages and in the macrophage subsets RM3/1 and 27E10. The glucocorticoid-inducible macrophage subtype RM3/1 is associated with antiinflammatory properties since it appears during the downregulatory phase ofthe inflammatory process and secretes anti-inflammatory proteins [5, 6]. The 27E10 subtype is found only in acute inflammatory reactions and produces large quantities of inflammatory mediators such as PGE2, TNF or IL-1, therefore exerting inflammatory effects [7, 8]. To investigate the expression ofthe IL-6 receptor in different macrophage maturation stages, cultures of human blood monocytes were obtained from buffy coats of healthy donors by twostep density gradient centrifugation [7]. They were cultured in hydrophobic Teflon bags in the absence (controls) or presence of lipopolysaccharide (1 µg/ ml), phorbolester (TPA; 10-8 M) or glucocorticoid (predny-lidene; 10-7 M). The macrophage subpopulations RM3/1 and 27E10 were isolated from 48-hour cultures treated with prednylidene or TPA, respectively, employing an indirect immunomagnetic sorting procedure using Paesel beads (Paesel-Lorei, Frankfurt, Germany) that resulted in a purity > 95% of either subset. For Northern blot analysis, total RNA was isolated from the macrophage cultures or from purified subtypes with Microspin columns. 10 µg RNA/lane were separated on a 1% denaturing
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